Investor Relations

Press Releases

Stock Price

Events

Repros' Investor and Analyst Day

October 31, 2014 at 7:30 AM Eastern

Biocentury’s NewsMakers in the Biotech Industry - New York

September 26, 2014

Repros Discusses ZA-305 Results

August 28, 2014




Receive Investor Alerts

About

We are a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.

Our current product pipeline (with the respective status of development) consists of the following:

Androxal®
Male Reproductive Health

Proellex®
Female Reproductive Health

Read More...

Pipeline

Pipeline
2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax